Comparison

Deruxtecan European Partner

Manufacturer MedChem Express
Category
Type Inhibitors
Specific against other
Amount 50mg
Item no. HY-13631E-50mg
CASRN 1599440-13-7
Available
Product Description
Deruxtecan is an ADC drug-linker conjugate composed of a derivative of DX-8951 (DXd) and a

maleimide-GGFG peptide linker, used for synthesizing DS-8201 and U3-1402.
StorageTemperature
-20°C, protect from light, stored under nitrogen; In solvent : -80°C, 6 months; -20°C, 1 month (protect from light, stored under nitrogen)
Applications
Cancer-programmed cell death
Formula
C52H56FN9O13
References
[1].NOGUCHI, Shigeru, et al. METHOD FOR SELECTIVELY MANUFACTURING ANTIBODY-DRUG CONJUGATE. WO2017002776A1. | [2].Ogitani Y, et al. Bystander killing effect of DS-8201a, a novel anti-human epidermal growth factor receptor 2 antibody-drug conjugate, in tumors with human epidermal growth factor receptor 2 heterogeneity. Cancer Sci. 2016 Jul; 107(7):1039-46.
MolecularWeight
1034.05
Research Area
Cancer
Solubility
DMSO : 35 mg/mL (33.85 mM; Need ultrasonic)
Target
Drug-Linker Conjugates for ADC
Isoform
Camptothecins
Pathway
Antibody-drug Conjugate/ADC Related

Note: The presented information and documents (Manual, Product Datasheet, Safety Datasheet and Certificate of Analysis) correspond to our latest update and should serve for orientational purpose only. We do not guarantee the topicality. We would kindly ask you to make a request for specific requirements, if necessary.

Amount: 50mg
Available: In stock
available

Delivery expected until 4/13/2023 

Compare

Add to wishlist

Request delivery time

Ask a technical question

Submit a bulk request

Questions about this Product?
 
Close